Learn more about malingering in this forensic psychiatry overview.

Can "healing" life trauma help improve bipolar disorder symptoms?

There has been a general increase in mental disorders and disturbances on all political and religious sides over years.

Calling it a barrier to care, FDA committees decide to end clozapine REMS.

What can we collectively be grateful for?

Conspiracy theories can lead individuals to engage in criminal and violent behaviors. It is necessary for psychiatrists treating or forensically evaluating individuals with conspiracy theories to be able to correctly identify different forms of belief.

How is the study of muscarinic receptors transforming schizophrenia treatment?

November is Men's Health Awareness Month.

The use of validated and scalable risk prediction tools can potentially improve mental health outcomes.

Here are 4 means of coping with the diagnostic uncertainty of bipolar mixed states.

Can paradoxical psychotherapy help us face our fears when it comes to society?

There are several points along this pathway for a justice involved patient to be intercepted and diverted to mental health treatment.

How can you best discuss long-acting injectable options with your patients living with schizophrenia?

What serendipitous, psychological meaning can we find in music in dark times?

Learn more about topics of interest in forensic psychiatry in this month's Special Report!

How can you handle patient gifts as a clinician?

"I say Good Morning! and he studies me in my white coat, like skin lesion he has seen only once in a textbook."

Is medicine a calling or a job?

A systematic review and meta-analysis showed moderate-quality evidence supporting lithium’s ability to lower mortality rates.

According to new data, NeuroStar Advanced TMS helped nearly 60% of adolescents with major depressive disorder.

Fill out this survey if you are a clinician who lactated while working.

Is it healthy to cut off family and friends due to political differences?

Check out new results of a pharmacokinetics study of AD04, an investigational therapeutic agent for the treatment of alcohol use disorder in patients with heavy drinking.

Gus Alva, MD, DFAPA; Carmen Kosicek, MSN, PMHNP-BC; and Roger McIntyre, MD, FRCPC wrap up the conversation discussing optimizing treatment response with a focus on rapid-acting antidepressants (ADTs), including real-world patient responses and clinical study data. They address patient education, treatment expectations, titration, and follow-up strategies to enhance treatment optimization and outcomes.

It's time for kindness...